Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore - Centre for Endoscopic Research Therapeutics and Training (CERTT), Rome, Italy (Luis Marín Calderón, Rossella Maresca, Frederico Barbaro, Cristiano Spada).
R L Maresca studies innovative endoscopic techniques for removing lesions and managing complications in the gastrointestinal tract, especially those related to conditions like inflammatory bowel disease and cancers. He investigates methods such as endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR), which are less invasive than traditional surgery and can lead to better patient outcomes. Additionally, his research looks into the effects of external factors like air pollution on liver health and how infections can influence treatment responses in patients with IBD.
Key findings
Endoscopic submucosal dissection (ESD) effectively removed gastric subepithelial lesions in 96.3% of cases with a complication rate of only 7%.
In a study on colon lesions, cancer was found in 12% of patients, and while 59.1% had non-curative resections, only 7.6% required additional surgery.
Patients treated with multistrain probiotics and vitamin D for irritable bowel syndrome showed a significant reduction in gut permeability markers by 19.5 ng/mL after 12 weeks.
Among 560 patients who had ESD wound closure, delayed bleeding occurred in 1.7% compared to 5.6% in those without closure, showing a clear benefit of this technique.
Twenty percentage of patients with large nonampullary duodenal tumors experienced recurrence within an average follow-up of 20.5 months, emphasizing the need for regular monitoring.
Frequently asked questions
Does Dr. Maresca study gastrointestinal bleeding?
Yes, Dr. Maresca has researched ways to manage gastrointestinal bleeding in cancer patients, focusing on new imaging techniques and advanced treatment options.
What treatments has Dr. Maresca researched?
He has studied endoscopic procedures like ESD and EMR, which are advanced methods for removing lesions in the gastrointestinal tract, as well as the effectiveness of probiotics for gut health.
Is Dr. Maresca's work relevant to patients with inflammatory bowel disease?
Absolutely, his research directly addresses treatment options and outcomes for patients with inflammatory bowel disease, including complications and the impact of air pollution on liver health.
What are the outcomes of treatments for colorectal lesions that Dr. Maresca researched?
The studies found that a significant percentage of patients undergoing endoscopic submucosal dissection had issues like non-curative resections and also highlighted the importance of careful patient selection to improve outcomes.
Can air pollution affect gastrointestinal health?
Yes, Dr. Maresca has found that air pollution can contribute to inflammation and liver conditions, making it an important area of study for patients at risk.
Publications in plain English
Postpartum intramuscular abscess of the biceps femoris in a patient with a history of intravenous drug use.
2026
Radiology case reports
Masino F, Maresca R, Tondo F, Murrone S, Fanigliulo G +6 more
Plain English This study looked at a rare infection that developed in the thigh of a 28-year-old woman who had recently given birth and had a history of using injectable drugs. After two weeks postpartum, she had a painful swollen thigh, and tests confirmed a large abscess in her muscle. Surgery and antibiotics led to her full recovery, showcasing the importance of recognizing such infections in postpartum women and using MRI for accurate diagnosis.
Who this helps: This helps postpartum women, particularly those with a history of drug use.
Endoscopic Management of Malignancy-Related Gastrointestinal Bleeding: A Comprehensive Narrative Review.
2026
Medical sciences (Basel, Switzerland)
Salvi D, Parmigiani M, Spada C, Olivari N, Piccirelli S +5 more
Plain English This study looks at how to manage bleeding in the gastrointestinal tract caused by cancer. It shows that about 10% of cancer patients experience this type of bleeding, which is often hard to control. New imaging techniques and advanced treatment options, like special clips and hemostatic powders, are improving the ability to quickly stop the bleeding and make treatment more effective.
Who this helps: This benefits cancer patients and their doctors by providing better treatment options for gastrointestinal bleeding.
Endoscopic submucosal dissection and submucosal tunneling endoscopic resection of gastric subepithelial lesions originating from the muscle layer: a multicenter retrospective study.
2026
Annals of gastroenterology
Dimitriadis S, Vogli S, Adrisani G, Tribonias G, Galasso D +26 more
Plain English This study looked at two advanced methods for removing gastric subepithelial lesions (SELs) that arise from the muscle layer of the stomach. Researchers found that these methods, endoscopic submucosal dissection (ESD) and submucosal tunneling endoscopic resection (STER), were effective in 96.3% of cases, with a low complication rate of 7% and very few recurrences (2.5% after about 9 months). This matters because these techniques can be safer alternatives to traditional surgery, especially for larger lesions or those growing outside the stomach lining.
Who this helps: Patients with gastric subepithelial lesions.
The Impact of Air Pollution on the Lung-Gut-Liver Axis: Oxidative Stress and Its Role in Liver Disease.
2025
Antioxidants (Basel, Switzerland)
Iaccarino J, Mignini I, Maresca R, Giansanti G, Esposto G +5 more
Plain English This study examined how air pollution affects a system in the body that connects the lungs, gut, and liver. Researchers found that pollutants can create harmful substances that lead to inflammation and damage, making liver diseases like fatty liver disease and cirrhosis more likely. Understanding these connections is important for developing better ways to prevent or treat liver issues caused by air pollution.
Who this helps: This helps patients at risk for liver disease due to air pollution.
Clinical outcomes of endoscopic mucosal resection for large superficial nonampullary duodenal epithelial tumor: a single-center study.
2025
European journal of gastroenterology & hepatology
Barbaro F, Papparella LG, Chiappetta MF, Schepis T, Maresca R +6 more
Plain English This study looked at a treatment called endoscopic mucosal resection (EMR) for large tumors in the duodenum, a part of the small intestine. Researchers reviewed the outcomes of 81 patients who had tumors over 1 cm in size from 2017 to 2021 and found that while 94% had their tumors successfully removed, 20% experienced recurrence within an average follow-up of 20.5 months, particularly among those with larger tumors or prior surgeries. This matters because, even though EMR can effectively treat these tumors, there is a significant chance they may come back, highlighting the need for regular check-ups.
Who this helps: Patients with large duodenal tumors and their doctors.
Effect of Prophylactic Colon ESD (Endoscopic Submucosal Dissection) Defect Closure on Post-ESD Outcomes: An International Multi-center Retrospective Study.
2025
Digestive diseases and sciences
Karna R, Sánchez JC, Josloff K, Tran T, Tiankanon K +27 more
Plain English This study looked at whether closing the wounds made during a specific colon procedure called endoscopic submucosal dissection (ESD) can help reduce complications, such as bleeding and the need to stay overnight in the hospital. The researchers found that among 560 patients, those who had their wounds closed experienced much lower rates of delayed bleeding (1.7% compared to 5.6%) and less need for overnight hospitalization. Specifically, closing the wounds reduced the risk of delayed bleeding for patients with right-sided polyps by more than half.
Who this helps: This benefits patients undergoing colon ESD, especially those with right-sided polyps.
Advanced diagnostic and resection endoscopic techniques in managing colitis-associated neoplasia: standard of care or still utopia?
2025
Best practice & research. Clinical gastroenterology
Maresca R, Calabrese G, Marchitto SA, Schepis T, Pecere S +5 more
Plain English This research looked at how to effectively detect and treat abnormal growths in patients with long-standing inflammatory bowel disease (IBD), which can lead to cancer. They found that choosing the right endoscopic technique is crucial: smaller lesions can be removed with a simpler method, while larger or tougher ones require more advanced techniques to ensure complete removal. Improving these methods is important because it can lead to better health outcomes and potentially reduce the need for major surgeries in patients at risk for cancer due to IBD.
Who this helps: This benefits patients with inflammatory bowel disease and their doctors.
Rates of Cancer, Non-curative Resection, Adverse Event and Surgery After Colonic Endoscopic Submucosal Dissection (ESD)-Results from a Large International Multicenter Study.
2025
Digestive diseases and sciences
Karna R, Sánchez JC, Josloff K, Tran T, Tiankanon K +27 more
Plain English This study looked at the outcomes of a procedure called endoscopic submucosal dissection (ESD) used to remove lesions from the colon, specifically focusing on how often cancer was found and how many patients needed further surgery. They found that cancer was present in 12% of the cases, and more than half (59.1%) of the patients had what is called non-curative resection, meaning the procedure didn’t completely remove the cancer. Importantly, only 7.6% of those with non-curative resections needed additional surgery, and there were some complications in 8.8% of patients. This information is important as it shows the need for careful patient and lesion selection to improve outcomes for those undergoing ESD.
Who this helps: This helps doctors and patients considering ESD for colon lesions.
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial.
2025
Nutrients
Laterza L, Cremon C, Coppola G, Settanni CR, Maresca R +14 more
Plain English This study looked at whether a combination of multistrain probiotics and vitamin D could improve gut health in people with irritable bowel syndrome (IBS) who don't have constipation. Researchers found that after 12 weeks, participants who took the probiotics and vitamin D had a notable decrease in a marker indicating gut permeability (zonulin) and better stool consistency compared to those who took a placebo. Specifically, they experienced a 19.5 ng/mL reduction in zonulin levels and improvements in stool quality and frequency.
Who this helps: This helps patients with irritable bowel syndrome, particularly those without constipation.
The Brain Tumor Segmentation - Metastases (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI.
2024
ArXiv
Moawad AW, Janas A, Baid U, Ramakrishnan D, Saluja R +227 more
Plain English The BraTS-METS 2023 challenge focused on improving how we identify and segment brain metastases (cancer spread to the brain) in MRI scans before treatment. The best performing algorithm scored a mean of 7.9 on how accurately it identified lesions, with a Dice score of 0.65. This is important because it highlights ongoing challenges in detecting smaller tumors and aims to enhance the accuracy of brain tumor evaluations, ultimately improving care for patients with brain metastases.
Who this helps: This benefits patients with brain metastases and their healthcare providers.
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.
2024
International journal of molecular sciences
Maresca R, Mignini I, Varca S, Calvez V, Termite F +6 more
Plain English This research paper looks at how inflammatory bowel diseases (IBD), like Crohn's disease and ulcerative colitis, are connected to non-alcoholic fatty liver disease (NAFLD), which is the most common liver issue globally. It finds that patients with IBD are more likely to develop NAFLD and its serious forms, such as liver scarring, with up to 50% experiencing liver-related complications. Understanding this link is crucial because it can help improve treatment and quality of life for IBD patients who also have liver problems.
Who this helps: This research benefits patients with inflammatory bowel diseases and their doctors.
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.
2024
Expert opinion on biological therapy
Tursi A, Mocci G, Scaldaferri F, Napolitano D, Maresca R +58 more
Plain English This study looked at the drug ustekinumab (UST) to see how well it works and how safe it is for patients with ulcerative colitis (UC). Researchers followed 256 patients and found that by 24 weeks, 27.6% of them achieved clinical remission, and 61.8% showed a clinical response. The study also noted that only a small number of patients experienced adverse effects (2.3%), which indicates that UST can be a safe and effective option for treating UC.
Who this helps: Patients suffering from ulcerative colitis.
Plain English This study looked at factors that contribute to the likelihood of Crohn's disease returning after surgery to remove part of the intestines. Out of 63 patients, 24 (38%) experienced a return of the disease within two years. Key findings showed that the older a patient was when they had the surgery, and specific characteristics of their disease, such as the location and extent of the affected bowel, increased the chances of recurrence.
Who this helps: This research benefits patients with Crohn's disease and their doctors by identifying risks that can inform treatment decisions.
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis.
2024
Journal of personalized medicine
Laterza L, Piscaglia AC, Bibbò S, Arena V, Brisigotti M +12 more
Plain English This study looked at patients with ulcerative colitis who appeared to have healed mucosal tissue but still had signs of ongoing disease activity in their tissue samples. Out of 100 patients, only 2 showed no remaining signs of disease. The research found that certain conditions in the tissue, like basal plasmacytosis and surface irregularity, were linked to a higher chance of the disease coming back; specifically, patients with these features were 2.98 to 4.50 times more likely to relapse.
Who this helps: This helps patients with ulcerative colitis and their doctors by identifying risks for disease reactivation.
Coronary calcifications as a new prognostic marker in COVID-19 patients: role of CT.
2023
European review for medical and pharmacological sciences
Maggialetti N, Torrente A, Lazzari P, Villanova I, Marvulli P +7 more
Plain English This study looked at how coronary artery calcification, which can be measured using CT scans, relates to death rates in patients with COVID-19. Researchers found that higher levels of calcification were linked to higher mortality rates: 10.1% of patients with no calcification died, while 46.4% of those with significant calcification (scores between 9 and 12) passed away. This is important because it shows that measuring heart artery calcification can help predict which COVID-19 patients are at greater risk of dying.
Who this helps: Patients with COVID-19 and their healthcare providers.
Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies.
2023
Thrombosis research
Papa A, Santini P, De Lucia SS, Maresca R, Porfidia A +4 more
Plain English This study looked at how the gut bacteria in patients with inflammatory bowel disease (IBD) can lead to an increased risk of dangerous blood clots. Researchers found that certain bacteria-related substances, like LPS and TMAO, may trigger these blood clot risks by causing ongoing inflammation, even when the disease isn't active. Understanding this connection is important because it can help develop new treatments aimed at restoring healthy gut bacteria and reducing the chances of blood clots.
Who this helps: This research benefits patients with inflammatory bowel disease and their doctors.
Nutrition in Acute Pancreatitis: From the Old Paradigm to the New Evidence.
2023
Nutrients
De Lucia SS, Candelli M, Polito G, Maresca R, Mezza T +7 more
Plain English This research paper looks at how nutrition is managed in patients with acute pancreatitis, highlighting a shift from an older method that involved resting the pancreas, to a newer approach that encourages early oral or tube feeding. The findings show that early feeding can lead to better outcomes, including a 30% lower risk of multiple-organ failure and reduced mortality rates. This is important because it suggests that changing how we feed patients could directly improve their chances of recovery.
Who this helps: This helps patients recovering from acute pancreatitis.
Predicting Treatment Response in Inflammatory Bowel Diseases: Cross-Sectional Imaging Markers.
2023
Journal of clinical medicine
Mignini I, Maresca R, Ainora ME, Larosa L, Scaldaferri F +2 more
Plain English This study looked at how doctors can better predict which treatments will work for patients with inflammatory bowel diseases (IBD), like Crohn's disease and ulcerative colitis, by using imaging techniques like ultrasounds and MRIs. Researchers found that specific imaging markers can help identify whether a patient will respond well to new biological drugs. This new approach can lead to more personalized treatment plans, improving patient care.
Who this helps: This helps patients with inflammatory bowel diseases.
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine.
2023
Cancers
Schepis T, De Lucia SS, Pellegrino A, Del Gaudio A, Maresca R +6 more
Plain English This study looked at the current state and future developments in treating pancreatic cancer, a type of cancer that is difficult to diagnose early and has high death rates. Researchers found that while surgery is the only way to potentially cure pancreatic cancer, most patients are diagnosed too late for this option. Improvements in surgical techniques and other therapies have made treatment safer and more effective, but a personalized approach is crucial for each patient to determine the best treatment plan.
Who this helps: This helps patients with pancreatic cancer and their doctors by providing better treatment options and strategies.
Radiomics could predict surgery at 10 years in Crohn's disease.
2023
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Laterza L, Boldrini L, Tran HE, Votta C, Larosa L +10 more
Plain English This study looked at how analyzing medical images can help predict whether patients with Crohn's disease will need surgery within the next 10 years. Researchers examined CT scans from 30 patients and developed a model that successfully identified patients at high risk for surgery with an accuracy of about 83%. This ability to predict surgery can help doctors monitor patients more closely and tailor treatments to those who need it most.
Who this helps: Patients with Crohn's disease and their doctors.
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment.
2023
Journal of clinical medicine
Maresca R, Varca S, Di Vincenzo F, Ainora ME, Mignini I +6 more
Plain English This research paper examines the role of cytomegalovirus (CMV) infection in patients with inflammatory bowel disease (IBD), especially those with ulcerative colitis. It highlights that IBD patients may be particularly vulnerable to CMV due to weakened immune systems, and discusses the ongoing debate about the best ways to diagnose CMV infections and their impact on treatment resistance, particularly concerning steroid medications. Addressing CMV infections may improve management of IBD, leading to better outcomes for patients.
Who this helps: Patients with inflammatory bowel disease, especially those struggling with treatment.
Is food refusal in autistic children related to TAS2R38 genotype?
2018
Autism research : official journal of the International Society for Autism Research
Riccio MP, Franco C, Negri R, Ferrentino RI, Maresca R +3 more
Plain English This study looked at whether genetic differences in how children taste bitterness affect their food preferences, particularly in children with autism spectrum disorder (ASD). Researchers tested 43 children with ASD and 41 typically developing children, finding that those with ASD who are sensitive to bitter tastes tend to refuse more foods. Specifically, they discovered a stronger presence of a specific gene variant related to bitter sensitivity in ASD children who are selective about food, which could help caregivers create better meal plans for these children.
Who this helps: This helps children with autism and their families by providing insights into managing food preferences.
Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.
2017
Mycopathologia
Iovene MR, Bombace F, Maresca R, Sapone A, Iardino P +7 more
Plain English This study examined the gut health of individuals with Autism Spectrum Disorders (ASD) and found that 57.5% of these subjects had high levels of a type of yeast called Candida, which was not present in healthy individuals. The researchers also discovered that individuals with ASD had lower levels of beneficial bacteria and signs of mild gut inflammation, which were linked to more severe symptoms of autism. Understanding these gut issues could lead to new treatments that improve health and quality of life for people with ASD.
Who this helps: This helps patients with autism and their families.
Lessons Learned: Accessing the Voice of Nurses to Improve a Novice Nurse Program.
2015
Journal for nurses in professional development
Maresca R, Eggenberger T, Moffa C, Newman D
Plain English This study looked at a training program for new nurses at a community hospital to see how well it supports them as they start their careers. The researchers found that gathering feedback from these novice nurses helped identify important lessons for improving the program. Specifically, listening to their experiences can lead to better support for new nurses, making their transition smoother and more effective.
Who this helps: This helps new nurses by improving their training and support as they begin their nursing careers.
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder.
2014
In vivo (Athens, Greece)
Gentile I, Zappulo E, Bonavolta R, Maresca R, Messana T +7 more
Plain English This study looked at whether children with autism spectrum disorder (ASD) have different levels of antibodies to two viruses, Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV), compared to healthy children. The researchers found that both groups had similar levels of these antibodies, but children with ASD who had CMV antibodies tended to have more severe symptoms. This is important because it helps clarify that while CMV and EBV might not directly cause ASD, they could be linked to the severity of the condition in some children.
Who this helps: This helps doctors and researchers working with children with autism.
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study.
2014
In vivo (Athens, Greece)
Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP +6 more
Plain English This study looked at how many children with autism spectrum disorder (ASD) have been exposed to the Varicella Zoster Virus (the virus that causes chickenpox) compared to healthy children. They found that 59% of the children with ASD had antibodies to this virus, compared to only 39% of the healthy controls, and the levels of these antibodies were much higher in the ASD group (694 mIU/ml vs. 94 mIU/ml). This finding is important because it suggests a possible link between exposure to this virus and the development of ASD, which could lead to new ways to understand and support children with this condition.
Who this helps: This helps researchers and healthcare providers working with children with autism.
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders.
2014
In vivo (Athens, Greece)
Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP +7 more
Plain English This study looked at the presence of antibodies to herpes simplex virus types 1 and 2 in children with autism spectrum disorders (ASD) compared to healthy children. Researchers tested 54 children with ASD and 46 healthy children and found no significant differences in antibody levels or rates of exposure to these viruses. This means that herpes simplex viruses do not appear to be linked to the development of autism spectrum disorders.
Who this helps: This research is useful for doctors and researchers studying the causes of autism.
Effect of caffeine ingestion on muscular strength and endurance: a meta-analysis.
2010
Medicine and science in sports and exercise
Warren GL, Park ND, Maresca RD, McKibans KI, Millard-Stafford ML
Plain English This study looked at how caffeine affects muscle strength and endurance based on 34 different research papers. It found that caffeine can boost muscle strength by about 7% in the knee extensors and enhance endurance in certain types of tests by roughly 18%. This is important because it shows that caffeine can help people perform better during physical activities.
Who this helps: This helps athletes and anyone looking to improve their physical performance.
Caffeines enhancement of maximal voluntary strength and activation in uninjured but not injured muscle.
2008
International journal of sport nutrition and exercise metabolism
Park ND, Maresca RD, McKibans KI, Morgan DR, Allen TS +1 more
Plain English This study looked at whether taking caffeine could help improve muscle strength and activation after injury. Researchers found that caffeine increased voluntary strength by 10.4% and muscle activation by 6.2% in healthy (uninjured) muscle but had no effect on injured muscle. These findings are important because they suggest that caffeine can help enhance strength in healthy muscles, which could be useful for athletes and active individuals.
Who this helps: This helps athletes and fitness enthusiasts looking to boost their muscle performance.
Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
2004
Vaccine
Mattion N, König G, Seki C, Smitsaart E, Maradei E +14 more
Plain English This research focused on the foot-and-mouth disease outbreaks in Argentina between 2000 and 2002, identifying different strains of the virus and improving vaccines to control the disease. The study found two main serotypes (O and A) and revealed that updating vaccines was crucial; after new vaccines were used, outbreaks decreased significantly, and over 75% of cattle developed protective antibodies. This is important because it shows how effective vaccination can control a serious livestock disease, ensuring food security and animal health.
Who this helps: This helps farmers, veterinarians, and the livestock industry.
Clinical study of gastrointestinal complications associated with clindamycin therapy.
1977
The Journal of infectious diseases
Swartzberg JE, Maresca RM, Remington JS
Plain English This study looked at gastrointestinal problems, specifically diarrhea, in 1,000 patients being treated with clindamycin. Researchers found that 6.6% of the patients experienced diarrhea, with higher rates among women and those over 20 years old, but the amount of the drug taken or how long it was used didn't affect the likelihood of getting diarrhea. Most of the patients who experienced diarrhea started having symptoms within two days of starting the medication, and on average, it lasted about 11 days.
Who this helps: This information helps doctors better understand the risks of clindamycin therapy and identify patients who may be more vulnerable to diarrhea.
Gastrointestinal side effects associated with clinidamycin. 1,000 consecutive patients.
1976
Archives of internal medicine
Swartzberg JE, Maresca RM, Remington JS
Plain English This study looked at how often diarrhea happens in patients taking clindamycin, an antibiotic, by examining 1,000 people. They found that 66 patients (6.6%) experienced diarrhea, and for three of those patients, it was severe. The study showed that older adults (over 20 years) and women were more likely to experience this side effect, while the amount of medication taken or how it was given did not affect the chances of having diarrhea.
Who this helps: This information helps doctors understand the risk of diarrhea with clindamycin, particularly in older women.